An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers.
Saved in:
| Title: | An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers. |
|---|---|
| Authors: | Elishmereni M; Institute for Medical Biomathematics, Bene-Ataroth, Israel., Kheifetz Y, Søndergaard H, Overgaard RV, Agur Z |
| Source: | PLoS computational biology [PLoS Comput Biol] 2011 Sep; Vol. 7 (9), pp. e1002206. Date of Electronic Publication: 2011 Sep 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
